(Q53349561)
Statements
The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. (English)
Krista L Dobo
Nigel Greene
Michelle O Cyr
Stéphane Caron
Warren W Ku
7 February 2006
44
3
282-293
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference